OCTAPUS-AI [COVID-19]

• Research type

  Research Study

• Full title

  Optimising Cancer Treatment surveillance and Ascertaining cause of Pneumonitis USing Artificial Intelligence

• IRAS ID

  283611

• Contact name

  Richard Lee

• Contact email

  richard.lee@rmh.nhs.uk

• Sponsor organisation

  The Royal Marsden NHS Foundation Trust

• Duration of Study in the UK

  10 years, 0 months, 1 days

• Research summary

  The study aims to develop and validate a machine learning classifier to distinguish between COVID-19 and cancer therapy (radiotherapy and immunotherapy) induced lung changes and to develop a prognostic machine learning signature for recurrence of non-small cell lung cancer following radical radiotherapy to stratify appropriate surveillance and onward care, thus minimising unnecessary hospital visits and resource use.\n\nData collected will allow identification of lung pathology in cancer patients related to therapy or COVID-19 induced pneumonitis and the prognostication and stratification of follow-up in NSCLC patients treated with radical thoracic radiotherapy in the COVID-19 era. [Study relying on COPI notice]

• REC name

  N/A

• REC reference

  N/A